###### Highlights

-   Sema3 (class 3 semaphorin)-F is a novel extraembryonic proangiogenic factor.

-   Sema3F inhibits the degradative phosphorylation of Myc on Thr58 in visceral yolk sac epithelial cells, both in vivo and in vitro.

-   In the mouse yolk sac, Sema3F fosters the transcription of members of the Myc-dependent proangiogenic miR-17/92 cluster.

-   Sema3F inhibits the synthesis of the Myc target and antiangiogenic protein thrombospondin 1 in visceral yolk sac epithelial cells, both in vivo and in vitro.

-   Sema3F promotes the phosphorylation of vascular endothelial growth factor receptor 2 in yolk sac vascular endothelial cells.

Effective delivery of oxygen and nutrients is mandatory for proper development of mammalian embryos.^[@R1]^ Although initially supported by molecular diffusion only, around day 8 of gestation (E8), the mouse embryo starts relying in full on blood circulation to further develop. By this time, heart starts beating and extraembryonic yolk sac blood islands, that is, mesoderm-derived clusters of hematopoietic cells surrounded by a layer of endothelial cells (EnCs), coalesce to form a vascular network filled with large nucleated primitive erythroblasts.^[@R2]^ This allows vital molecules to diffuse from the maternal blood, which is contained in giant trophoblast cell-lined uterine sinuses, into visceral yolk sac blood vessels that directly connect to the embryonic vasculature. Between E12.5 and E14.5, the mature chorioallantoic placenta progressively replaces the yolk sac as main nutrient exchange organ supporting the development of the mouse embryo.^[@R3]^

Large embryonic blood vessels and the vasculature of several embryonic organs and extraembryonic yolk sac initially arise by vasculogenesis, namely, the differentiation of angioblasts into EnCs that self-assemble in a homogeneously-sized primitive vascular plexus.^[@R1]^ The latter is then remodeled by angiogenesis into a hierarchically sized mature vascular tree that facilitates and optimizes the distribution of blood.^[@R1]^ In this context, EnC mechanosensitive adhesion receptors translate blood fluid shear traction forces into biochemical signals that allow vascular remodeling and maturation.^[@R4]^ Although it is well established that extraembryonic EnCs do not contribute to intraembryonic blood vessels, the molecular mechanisms that differentially regulate yolk sac and embryonic vascularization are poorly defined.^[@R1]^

Sema3 (class 3 semaphorins) are secreted guidance cues that in the developing embryo signal through the cytosolic GAP (GTPase-activating protein) domain of Plexin receptors^[@R5]^ to inhibit R-Ras, M-Ras, and Rap1, 3 small GTPases that are crucial positive regulators of integrin-mediated cell adhesion in different cell types, EnC included.^[@R6],[@R7]^ The chemorepulsive activity of Sema3A^[@R8]--[@R10]^ and Sema3E^[@R11]^ was previously reported to control the vascular patterning in chick, zebrafish, and mouse embryos.^[@R12]^ In addition, thanks to their ability to inhibit angiogenesis, both Sema3A and Sema3E exert an effective anticancer activity.^[@R13],[@R14]^ Similarly, Sema3F was also found to display powerful antiangiogenic and antitumor effects^[@R13],[@R14]^; however, if and how Sema3F may play a role in embryonic vascular development is unknown. Surprisingly, at odds with the antiangiogenic function of all other Sema3 proteins, here we unveil how Sema3F drives a Myc-dependent proangiogenic program that is selectively restricted to the extraembryonic vasculature. In addition to shedding light on the molecular mechanisms that selectively drive extraembryonic but not embryonic blood vessel formation, our findings also suggest how an aberrant expression of Sema3F might be involved in placenta vascular malformations.

Materials and Methods
=====================

Materials and Methods are available in the [online-only Data Supplement](http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.117.308226/-/DC1).

Results
=======

Targeted Disruption of Mouse *Sema3f* Gene Results in Partially Penetrant Embryonic Lethality but Does Not Control Embryonic Vascular Development
-------------------------------------------------------------------------------------------------------------------------------------------------

To understand whether Sema3F may control both embryonic and postnatal mouse development, we characterized and compared *Sema3f*- and, for control purposes, *Sema3a*-null mice.^[@R8]^ Heterozygous *Sema3a* and *Sema3f* mice were phenotypically normal and fertile. As expected,^[@R8]^ the percentage of born *Sema3a*-null mice was also much lower than the Mendelian ratio (5.7% *Sema3a*^−/−^, 39.1% *Sema3a*^+/+^, 55.2% *Sema3a*^+/−^; n=460). Similarly, Walz et al^[@R15]^ already described that *Sema3f*^−/−^ mice were born significantly less (14%) than that predicted by Mendelian ratio. As shown in Table [1](#T1){ref-type="table"}, we confirmed that the frequency of born *Sema3f*-knockout pups is indeed lower than expected (5.7% *Sema3f*^−/−^, 29.4% *Sema3f*^+/+^, 64.9% *Sema3f*^+/−^; n=465). The higher embryonic lethality we observed in our *Sema3f*^−/−^ mice compared with that reported by Walz et al^[@R15]^ might be likely because of differences in the percentage of C57Bl/6 and 129P2/OlaHsd genetic backgrounds between the 2 colonies (see Materials and Methods and Figure I in the [online-only Data Supplement](http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.117.308226/-/DC1)). Thus, similarly to *Sema3a*^−/−^ mice, most of *Sema3f*-null mice also die in utero.

###### 

Genotypes of the Offspring Generated From *Sema3f* and *Sema3a* Heterozygous Intercrosses on a C57BL/6 Background

![](atv-37-1710-g001)

To assess the timing of embryolethality, we genotyped embryos collected at different developmental stages. Between E9.5 and E10.5, a clear significant decrease in *Sema3f*- and *Sema3a*-null embryos emerged. In particular, the *Sema3f*-null embryos were 19.6% at E9.5 (n=249) and 13.5% at E10.5 (n=81), whereas those of *Sema3a*-null embryos were 18.6% at E9.5 (n=285) and 15.2% at E10.5 (n=105). No gross phenotypic differences were present in the few outliving *Sema3f*- or *Sema3a*-knockout mice. However, as previously reported,^[@R16]^ if matched with wild-type mice of the same litter, 3-week-old *Sema3a*^−/−^ mice were smaller in size, their weight was halved, and they had difficulty maintaining an upright posture.

Sema3A signaling was previously reported to control vascular morphogenesis in zebrafish,^[@R9]^ chick,^[@R10]^ and mouse embryos.^[@R8],[@R17]--[@R19]^ We hence investigated whether, similar to Sema3A, Sema3F may also regulate mouse embryonic angiogenesis. We examined by fluorescence confocal microscopy the vasculature of whole-mount endomucin-stained wild type (Figure [1](#F1){ref-type="fig"}A through [1](#F1){ref-type="fig"}D), *Sema3f*-null (Figure [1](#F1){ref-type="fig"}F through [1](#F1){ref-type="fig"}I), and *Sema3a*-null (Figure [1](#F1){ref-type="fig"}K through [1](#F1){ref-type="fig"}N) embryos at E9.5. Compared with control littermates (Figure [1](#F1){ref-type="fig"}E), *Sema3f*- knockout embryos (Figure [1](#F1){ref-type="fig"}J) displayed retarded growth (E9.5 wild-type embryos: 21.2±0.5 somites; E9.5 *Sema3f*^−/−^ embryos: 18.8±0.5 somites; Table [2](#T2){ref-type="table"}) but not major vascular defects (Figure [1](#F1){ref-type="fig"}A through [1](#F1){ref-type="fig"}D and [1](#F1){ref-type="fig"}F through [1](#F1){ref-type="fig"}I). In agreement with previous studies^[@R8]^ and differently from *Sema3f*-null embryos (Figure [1](#F1){ref-type="fig"}J), *Sema3a*-knockout embryos (Figure [1](#F1){ref-type="fig"}O) displayed an even stronger growth retardation (E9.5 *Sema3a*^−/−^ embryos: 17±1.2 somites, n=7; Figure [1](#F1){ref-type="fig"}O) that was associated with angiogenic remodeling defects (Figure [1](#F1){ref-type="fig"}K through [1](#F1){ref-type="fig"}N). The cephalic plexus of wild-type (Figure [1](#F1){ref-type="fig"}B and [1](#F1){ref-type="fig"}C) and *Sema3f*^−/−^ (Figure [1](#F1){ref-type="fig"}G and [1](#F1){ref-type="fig"}H), but not *Sema3a*^−/−^ E9.5 embryos (Figure [1](#F1){ref-type="fig"}L and [1](#F1){ref-type="fig"}M), was stereotypically reshaped into a pattern wherein cephalic veins were discernible. Moreover, in E9.5 wild-type (Figure [1](#F1){ref-type="fig"}D) and *Sema3f*-null (Figure [1](#F1){ref-type="fig"}I) but not *Sema3a*-null (Figure [1](#F1){ref-type="fig"}N) embryos, the dorsal longitudinal anastomotical vessel started to be remodeled into a mature perineural capillary plexus.

###### 

Number of Intersomitic Vessels Evaluated in *Sema3f*, *Sema3a*, and *Sema3a/Sema3f*-Knockout Embryos (E9.5)

![](atv-37-1710-g002)

![Sema3 (class 3 semaphorin)-A is necessary for embryonic angiogenic remodeling, whereas Sema3F is required for yolk sac blood vessel formation. Whole-mount endomucin stained E9.5 wild-type (**A** through **D**), *Sema3f*^−/−^ (**F** through **I**), and *Sema3a*^−/−^ (**K** through **N**) embryos. The cephalic plexus of wild-type (**B** and **C**) and *Sema3f*^−/−^ (**G** and **H**) but not *Sema3a*^−/−^ (**L** and **M**) embryos is remodeled to give rise to easily distinguishable cephalic veins. The cephalic perineural vascular plexus develops through remodeling of the dorsal longitudinal anastomotical vessel in wild-type (**D**) and *Sema3f*^−/−^ (**I**) but not in *Sema3a*^−/−^ embryos (**N**). **E**, **J**, and **O**, Stereomicroscopic analyses reveals how, when compared with age-matched wild-type embryos (**E**), the development of both *Sema3f*^−/−^ (**J**) and *Sema3a*^−/−^ (**O**) E9.5 embryos is delayed. Developmental delay is more severe in *Sema3a*^−/−^ (**O**) than that in *Sema3f*^−/−^ (**J**) embryos. **B**, **G**, and **L**, Magnifications of the top boxed areas in (**A**), (**F**), and (**K**), respectively. **C**, **H**, and **M**, Magnifications of the boxed areas in (**B**), (**G**), and (**L**), respectively. **D**, **I**, and **N**, Magnifications of the bottom boxed areas in (**A**), (**F**), and (**K**), respectively. Scale bars, 300 μm (**A**, **F**, and **K**) and 100 μm (**E**, **J**, and **O**). Stereomicroscopy (**P** through **U**) and endomucin-staining confocal microscopy (**V** through **AA**) analyses of E10.5 wild-type (**P**, **Q**, **V**, and **W**), *Sema3f*^−/−^ (**R**, **S**, **X**, and **Y**) and *Sema3a*^−/−^ (**T**, **U**, **Z**, and **AA**) yolk sacs. When compared with wild-type yolk sacs (**P**, **Q**, **V**, and **W**), a dramatic decrease in blood vessels is observed in *Sema3f*^−/−^ yolk sacs (**R**, **S**, **X**, and **Y**), while a poorly remodeled primary capillary plexus and the persistence of some blood islands characterize *Sema3a*^−/−^ (**T**, **U**, **Z**, and **AA**) yolk sacs. **Q**, **S**, **U**, **W**, **Y**, and **AA**, Magnifications of (**P**), (**R**), (**T**), (**V**), (**X**), and (**Z**), respectively. Scale bars, 100 μm (**P**, **R**, and **T**) and 150 μm (**V**, **X**, and **Z**).](atv-37-1710-g003){#F1}

Sema3F Drives Extraembryonic Angiogenesis
-----------------------------------------

In quest of explanations for the growth retardation associated with an essentially normal vascular development of *Sema3f*- knockout embryos, we reasoned that it may be due to defective angiogenesis in extraembryonic organs, namely, yolk sac and placenta. Accordingly, we observed that, although yolk sacs of E10.5 wild-type embryos contained a dense hierarchically ordered vascular network (Figure [1](#F1){ref-type="fig"}P, 1Q, 1V, and 1W), *Sema3f*-null yolk sacs unexpectedly displayed a dramatic reduction in blood vessel number and organization into a mature vascular tree (Figure [1](#F1){ref-type="fig"}R, 1S, 1X, and 1Y). *Sema3f* ^−/−^ mice placentas were also highly anemic and abnormally vascularized (Results section; Discussion section, and Figure II in the [online-only Data Supplement](http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.117.308226/-/DC1)). A not remodeled primary vascular plexus and occasional scattered blood islands were instead present in *Sema3a*-null yolk sacs (Figure [1](#F1){ref-type="fig"}T, 1U, 1Z, and 1AA).

The mouse yolk sac consists of mesoderm-derived blood islands and vessels that are positioned between endoderm-derived visceral yolk sac (VYS) epithelial cell (EpC) layer and parietal yolk sac (PYS) EpC layer.^[@R20]^ VYS EpCs control nutrient and gas exchanges and the development of blood islands and vessels; PYS EpCs instead protect the embryo.^[@R20]^ To understand which cell types synthesize Sema3F and express the major Sema3F coreceptor Nrp2, we performed confocal microscopy analyses on E9.5 yolk sacs that were double stained with either anti-Sema3F or anti-Nrp2 and antibodies recognizing vascular EnC or VYS EpC or PYS EpC markers, respectively, represented by endomucin, cytokeratin 8/18 (CK8/18), and Snail1 proteins.^[@R21]^ Sema3F protein was present in VYS EpCs and in part also in vascular EnCs of *Sema3f*^+/+^ but not in *Sema3f*^−/−^ yolk sacs (Figure [2](#F2){ref-type="fig"}A and [2](#F2){ref-type="fig"}C). PYS EpCs essentially do not produce Sema3F (Figure [2](#F2){ref-type="fig"}A and [2](#F2){ref-type="fig"}C). We next analyzed the expression of Sema3F in E9.5 embryos. As illustrated in Figure IIIC and IIID in the [online-only Data Supplement](http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.117.308226/-/DC1), Sema3F was mainly expressed in vascular EnCs of both wild-type and *Sema3a*^−/−^, but not in *Sema3f*^−/−^, embryos. Similarly, Sema3A was expressed in endomucin^+^ vessels of *Sema3f*^−/−^ yolk sacks (Figure IIIA and IIIB in the [online-only Data Supplement](http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.117.308226/-/DC1)).

![Sema3 (class 3 semaphorin)-F and Nrp2 are mainly expressed by the CK8/18 (cytokeratin 8/18)^+^ epithelial cells of the yolk sac. Frozen sections of yolk sacs were decorated for Sema3F (red) in costaining alternatively with endomucin, CK8/18, or Snail1 antibodies (green) and Dapi (4′,6-diamidino-2-phenylindole; blue). **A**, Sema3F largely colocalized with the CK8/18 visceral epithelial cells marker. As expected, no Sema3F expression was detected in *Sema3f*^−/−^ samples. **B**, Confocal analysis showed that in both *Sema3f*^+/+^ and *Sema3f*^−/−^ mice, Nrp2 is greater expressed by the visceral yolk sac as assessed by Nrp2-CK8/18 costaining. Confocal analysis was performed on tissue sections from 6 mice per group; scale bars, 100 μm. **C** and **D**, Graphs show the percentage of Sema3F and Nrp2 colocalization with endomucin, CK8/18, and Snail1 in both *Sema3f*^+/+^ and *Sema3f*^−/−^ yolk sacs (\*\**P*\<0.01, Student *t* test).](atv-37-1710-g004){#F2}

We also observed that Nrp2, the major Sema3F coreceptor, is expressed in VYS EpCs and vascular EnCs but not in PYS EpCs (Figure [2](#F2){ref-type="fig"}B and [2](#F2){ref-type="fig"}D). Thus, in the yolk sac, Nrp2-expressing EnCs and VYS EpCs may be stimulated by paracrine/autocrine Sema3F.

Sema3F Signaling Inhibits the Degradation of Myc Transcription Factor in Visceral Yolk Sac Epithelial Cells
-----------------------------------------------------------------------------------------------------------

Our data indicate that, at odds with its well-characterized antiangiogenic effects reported in the adult animal,^[@R13]^ Sema3F plays a proangiogenic role in extraembryonic tissues. Because it is well documented that in EnCs Sema3F elicits canonical antiangiogenic signals,^[@R22]^ we considered the option that Sema3F might exert its proangiogenic activity at least in part by controlling gene transcription in extraembryonic tissues, for example, by acting on Nrp2-expressing VYS EpCs. In this regard, the basic helix-loop-helix transcription factor Myc is a well-established regulator of vascular development,^[@R23]^ and in *Caenorhabditis elegans*, a Myc-like network was found to cooperate with semaphorin signaling in the control of cell migration.^[@R24]^ Hence, we first assessed whether the loss of *Sema3f* was associated with the modulation of yolk sac Myc protein expression. Confocal immunofluorescence analysis on E9.5 wild-type and *Sema3f*^−/−^ yolk sacs revealed how Myc protein was decreased by 0.73-fold in *Sema3f*-knockout animals (Figure [3](#F3){ref-type="fig"}A and [3](#F3){ref-type="fig"}B).

![Sema3 (class 3 semaphorin)-F activates a Myc- and miR-18a/miR-19b--dependent proangiogenic pathway in the mouse yolk sac. **A** and **B**, Quantification of immunofluorescence analysis of E9.5 yolk sacs using Myc antibody (red) counterstained with Dapi (4′,6-diamidino-2-phenylindole; blue) showed that Myc expression decreases by 0.73-fold in *Sema3f*^−/−^ yolk sacs. **C** and **D**, Myc phosphorylation at Thr58 significantly increased in E9.5 *Sema3f*^−/−^ yolk sacs compared with the wild type. Furthermore, a double staining with anti-p-Myc (Thr58) and either anti-endomucin or anti--cytokeratin 8/18 (CK8/18), or anti-Snail1 revealed that p-Myc (Thr58) is mainly expressed in CK8/18+ visceral yolk sac epithelial cells, whereas only few amounts of Thbs1 were associated with endomucin^+^ vascular endothelial cells. **E**, Real-time polymerase chain reaction revealed how, compared with wild-type yolk sacs, proangiogenic miR-18a and miR-19b diminished in *Sema3f*^−/−^ yolk sacs. (\*\*\**P*\<0.0001; \*\**P*\<0.01; \**P*\<0.05, Student *t* test). Scale bars, 100 μm.](atv-37-1710-g005){#F3}

Myc protein stability is regulated by phosphorylation and ubiquitin-dependent degradation. In particular, GSK3 (glycogen synthase kinase 3)-mediated phosphorylation of Myc at Thr58 gives rise to a binding site that is directly recognized by the E3 ubiquitin ligase Fbw7(F-box and WD repeat domain-containing 7), resulting in ubiquitination followed by proteasomal degradation of Myc.^[@R25]^ Consistent with previous in vitro data,^[@R25]^ we found that in E9.5 *Sema3f*^−/−^ yolk sacs the reduction in Myc protein amount was associated with a selective increase of Myc Thr58 phosphorylation in VYS EpCs, but neither in PYS EpCs nor in EnCs (Figure [3](#F3){ref-type="fig"}C and [3](#F3){ref-type="fig"}D). Altogether, our findings support a model in which in the mouse yolk sac paracrine/autocrine Sema3F signals to inhibit the (GSK3-dependent) phosphorylation on Thr58 and ensuing degradation of the proangiogenic Myc transcription factor in VYS EpCs. Hence, paracrine/autocrine Sema3F signals inhibit the phosphorylation on Thr58 and ensuing degradation of Myc in VYS EpCs.

Sema3F Promotes the Transcription of Myc-Regulated AngiomiRs in the Mouse Yolk Sac
----------------------------------------------------------------------------------

Myc may drive yolk sac blood vessel development downstream of Sema3F signaling by promoting the transcription of different proangiogenic genes.^[@R23],[@R26]^ In particular, it was reported that in cultured embryonic stem cells, Myc loss impairs *Vegfa* (vascular endothelial growth factor A) gene expression.^[@R23]^ However, even if Myc protein abundance was dramatically decreased (Figure [3](#F3){ref-type="fig"}A and [3](#F3){ref-type="fig"}B), we did not detect any significant reduction of *Vegfa* mRNA in *Sema3f*-null yolk sacs, as evaluated by real-time quantitative polymerase chain reaction (Figure IVA in the [online-only Data Supplement](http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.117.308226/-/DC1)). These findings indicate that in the mouse yolk sac, Sema3F should induce the transcription of additional Myc-dependent proangiogenic genes other than *Vegfa*.

Specific miRNA genes, dubbed angiomiRs, are master regulators of developmental angiogenesis and transcription of the key proangiogenic miR-17/92 cluster^[@R26]^ lies under the control of Myc.^[@R27]^ Thus, we considered the possibility that Myc protein downmodulation in *Sema3f*^−/−^ yolk sacs may impair miR-17/92 gene cluster transcription. By real-time quantitative polymerase chain reaction, we analyzed the transcription of genes belonging to miR-17/92 cluster in E9.5 wild-type and *Sema3f* ^−/−^ yolk sacs. Among miR-17/92 gene cluster members, miR-18a and miR-19b-1 emerged as the most modulated miRNAs in *Sema3f* ^−/−^ yolk sacs. Compared with wild type, miR-18a and miR-19b-1 levels, respectively, decreased by 0.5- and 0.8-fold in *Sema3f* ^−/−^ yolk sacs (Figure [3](#F3){ref-type="fig"}E). Hence, Sema3F signaling drives the Myc-mediated transcription of the proangiogenic miR 17/92 cluster members miR-18a and miR-19b-1.

Sema3F Inhibits the Expression of the Antiangiogenic Factor Thbs1 (Thrombospondin 1) in Mouse Visceral Yolk Sac Epithelial Cells
--------------------------------------------------------------------------------------------------------------------------------

Thbs1 (thrombospondin 1) is an effective angiogenesis inhibitor^[@R28]^ whose expression is inhibited by Myc protein^[@R23]^ and Myc-induced miR-17/92 cluster miRNAs,^[@R29]^ in particular, miR-18a and miR-19b-1.^[@R30]--[@R32]^ To assess whether Thbs1 expression was modulated in E9.5 *Sema3f* ^−/−^ yolk sacs compared with their wild-type counterpart, we first analyzed *Thbs1* gene transcription by real-time quantitative polymerase chain reaction (Figure IVB in the [online-only Data Supplement](http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.117.308226/-/DC1)). Compared with wild-type yolk sacs, *Thbs1* mRNA levels increased by 1.5-fold in *Sema3f* ^−/−^ yolk sacs. Next, we assessed Thbs1 protein expression by confocal immunofluorescence microscopy. Quantitave analysis revealed that, in comparison to wild-type yolk sacs, Thbs1-positive areas increased by 2.5-fold in *Sema3f* ^−/−^ yolk sacs (Figure [4](#F4){ref-type="fig"}A and [4](#F4){ref-type="fig"}B).

![Sema3 (class 3 semaphorin)-F signaling inhibits Thbs1 (thrombospondin 1) protein expression. **A** and **B**, Quantification of immunofluorescence analyses of E9.5 yolk sacs showed that Thbs1 expression increases by 2.5-fold in *Sema3f*^−/−^ yolk sacs. Scale bars, 300 μm (\*\**P*\<0.001; \*\*\**P*\<0.0001, Student *t* test). **C**, Confocal analysis showed that Thbs1 protein expression is enriched in CK8/18 (cytokeratin 8/18)^+^ visceral yolk sac epithelial cells compared with the other cell types. Scale bars, 100 μm. **D**, Bar graph shows the percentage of Thbs1 colocalization with endomucin, CK8/18, and Snail1 in both wild-type and *Sema3f*^−/−^ yolk sacs (\*\**P*\<0.001, Student *t* test).](atv-37-1710-g006){#F4}

To understand which cell type(s) synthesize Thbs1, we analyzed by confocal microscopy E9.5 yolk sacs that were double stained with anti-Thbs1 and either antiendomucin or anti-CK8/18, or anti-Snail1. We detected Thbs1 protein mainly in CK8/18^+^ VYS EpCs, whereas only a few amount of Thbs1 was associated with endomucin^+^ vascular EnCs (Figure [4](#F4){ref-type="fig"}C and [4](#F4){ref-type="fig"}D). Of note, we did not observe any difference in the expression of Thbs2 in the different cell types of *Sema3f*^−/−^, compared with wild-type yolk sacs (Figure V in the [online-only Data Supplement](http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.117.308226/-/DC1)).

It has been clearly documented how Thbs1 effectively impairs VEGFA function mostly by inhibiting VEGF-R2 (VEGF receptor 2 phosphorylation).^[@R28],[@R33],[@R34]^ Therefore, we investigated whether endothelial VEGF signaling may be affected in *Sema3f*-knockout yolk sacs and uncovered that indeed tyrosine phosphorylation VEGF-R2 was reduced dramatically in vascular EnCs of E9.5 *Sema3f* ^−/−^ yolk sacs (Figure [5](#F5){ref-type="fig"}). Hence, in *Sema3f*-null yolk sacs, VYS EpCs synthesize high amount of Thbs1 protein that in turn effectively impairs VEGF-R2 activation in vascular EnCs.

![*Sema3f*-knockout impairs VEGF-R2 (vascular endothelial growth factor receptor R2) phosphorylation in the yolk sac. **A**, Confocal microscopy analysis showed that VEGF-R2 phosphorylation is strongly reduced in *Sema3f*^−/−^ yolk sacs compared with wild-type controls, whereas VEGF-R2 expression is not affected. Scale bars, 100 μm. **B**, Percentage of p-VEGF-R2 and total VEGF-R2 relative levels in endomucin^+^ endothelial cell. (\*\*\**P*\<0.0001, Student *t* test). Sema3 indicates class 3 semaphorin.](atv-37-1710-g007){#F5}

In In Vitro Differentiated VYS EpCs, Exogenous Recombinant Sema3F Inhibits the Myc-Dependent Expression of the Antiangiogenic Factor Thbs1
------------------------------------------------------------------------------------------------------------------------------------------

To directly assess whether Sema3F may stimulate Myc protein accumulation and the decrease of the antiangiogenic factor Thbs1, we set up an in vitro system to create differentiated CK8/18^+^ VYS Eps that may then be treated with recombinant Sema3F (rSema3F). To this aim, we exploited the well-characterized in vitro model of F9 testicular teratocarcinoma stem cells that, when cultured as aggregates in suspension and stimulated with retinoic acid, differentiate in VYS Eps.^[@R35],[@R36]^ Fluorescent confocal microscopy confirmed that, similar to what observed in the mouse yolk sac (Figure [2](#F2){ref-type="fig"}B and [2](#F2){ref-type="fig"}D), in vitro differentiated CK8/18^+^ VYS EpCs expressed Sema3F receptor Nrp2 as well (Figure [6](#F6){ref-type="fig"}A). Of note, quantitative analysis of immunofluorescent staining revealed how exogenously added rSema3F effectively inhibits the degradative GSK-dependent phosphorylation of Myc on Thr58 (Figure [6](#F6){ref-type="fig"}B and [6](#F6){ref-type="fig"}D) and increases total Myc protein levels (Figure [6](#F6){ref-type="fig"}B and [6](#F6){ref-type="fig"}D), while significantly decreasing Thbs1 (Figure [6](#F6){ref-type="fig"}C and [6](#F6){ref-type="fig"}D), whose expression is known to be inhibited by Myc.^[@R23]^ Thus, direct in vitro stimulation of cultured VYS Eps with rSema3F promotes the accumulation of Myc and impairs the expression of the antiangiogenic factor Thbs1.

![Exogenous recombinant Sema3 (class 3 semaphorin)-F impairs Myc degradation and inhibits Thbs1 (thrombospondin 1) expression in in vitro differentiated visceral yolk sac (VYS) epithelial cells (EpCs). **A**, Mouse F9 teratocarcinoma stem cells differentiated in VYS EpCs express Sema3F receptor Nrp2, as revealed by immunofluorescence staining. **B**, Stimulation with exogenous rSema3F increases Myc expression and reduces Myc Thr58 phosphorylation in in vitro differentiated VYS EpCs derived from mouse F9 teratocarcinoma stem cells. **C**, rSema3F stimulation also decreases the expression of antiangiogenic Thbs1 protein in VYS EpCs derived from mouse F9 teratocarcinoma stem cells. **D**, The relative fluorescence intensity of Myc, Thr58 phosphorylated Myc, and Thbs1 was measured in VYS EpCs derived from mouse F9 teratocarcinoma stem cells stimulated or not with rSema3F. Data are mean±SEM. n=15 cell aggregates per condition pooled from 3 independent experiments. (\*\*\**P*\<0.0001; \**P*\<0.05, Student *t* test). Scale bars, 25 μm.](atv-37-1710-g008){#F6}

*Sema3a Sema3f* Double Knockdown Results in Early Mouse Embryonic Lethality and Severely Impairs Both Embryonic and Extraembryonic Angiogenesis
-----------------------------------------------------------------------------------------------------------------------------------------------

To understand whether Sema3A and Sema3F may cooperate in regulating embryonic development, we first mated *Sema3a*^+/−^ and *Sema3f*^+/−^ mice to create double *Sema3a*^+/−^ *Sema3f*^+/−^ mice that in F1 progeny were born in a normal Mendelian ratio. Then, to generate double *Sema3a/Sema3f*-knockout mice, *Sema3a*^+/−^ *Sema3f*^+/−^ animals were mated. Among 405 weaned mice, no double *Sema3a*^−/−^ *Sema3f* ^−/−^ mice were born. These data indicate that all double *Sema3a Sema3f*-knockout mice died in utero. To assess the time of embryo lethality, double *Sema3a*^−/−^ *Sema3f* ^−/−^ embryos were genotyped at different gestation times, observing a large loss of double *Sema3a*^−/−^ *Sema3f* ^−/−^ embryos around E9.5 (Table [3](#T3){ref-type="table"}).

###### 

Genotypes of Progeny from *Sema3a+/−/Sema3f+/−* Intercrosses

![](atv-37-1710-g009)

Compared with wild-type animals (Figure [7](#F7){ref-type="fig"}D), *Sema3a*^−/−^ *Sema3f* ^−/−^ embryos were significantly smaller (Figure [7](#F7){ref-type="fig"}H), and their growth delay at E9.5 was more important than that observed in *Sema3a*^−/−^ embryos (Figure [1](#F1){ref-type="fig"}O). In fact, on average, at E9.5, *Sema3a*^−/−^ *Sema3f* ^−/−^ embryos displayed 11 somites compared with the 21 somites of wild-type littermates (Table [2](#T2){ref-type="table"}). Confocal immunofluorescence microscopy on whole-mount endomucin-stained *Sema3a*^−/−^ *Sema3f* ^−/−^ embryos (Figure [7](#F7){ref-type="fig"}E through [7](#F7){ref-type="fig"}G) unveiled how vascular abnormalities were considerably more severe than those observed in *Sema3a*-null mice (Figure [1](#F1){ref-type="fig"}K through [1](#F1){ref-type="fig"}N). In particular, compared with wild-type embryos (Figure [7](#F7){ref-type="fig"}A through [7](#F7){ref-type="fig"}C), both cephalic vascular plexus (Figure [7](#F7){ref-type="fig"}E and [7](#F7){ref-type="fig"}F) and intersomitic blood vessels (Figure [7](#F7){ref-type="fig"}E and [7](#F7){ref-type="fig"}G) were poorly formed and, when formed, they were not remodeled. Short noninterconnected sprouts enclosed wide avascular spaces. Next, we evaluated the impact of *Sema3a Sema3f*-double knockout on yolk sac vascularization. Because of the difficulties in recovering viable double *Sema3a*^−/−^ *Sema3f*^−/−^ mutant embryos at E10.5, we decided to analyze the vasculature of E9.5 yolk sacs, which, differently from wild-type yolk sacs (Figure [7](#F7){ref-type="fig"}I), appeared extremely pale and essentially avascular (Figure [7](#F7){ref-type="fig"}J). Thus, abnormalities of *Sema3a*^−/−^ *Sema3f*^−/−^ yolk sac blood vessels (Figure [7](#F7){ref-type="fig"}J) were considerably more serious than those observed in either *Sema3f*^−/−^ (Figure [1](#F1){ref-type="fig"}R, 1S, 1X, and 1Y) or *Sema3a*^−/−^ (Figure [1](#F1){ref-type="fig"}T, 1U, 1Z, and 1AA) yolk sacs.

![Sema3 (class 3 semaphorin)-F and Sema3A cooperate to control developmental angiogenesis. Whole-mount endomucin-stained E9.5 wild-type (**A**, **B**, and **C**) and *Sema3a*^−/−^ *Sema3f*^−/−^-double knockout (**E**, **F**, and **G**) embryos. Remodeling of the cephalic plexus into veins occurs in wild type (**A** and **B**) but not in *Sema3a*^−/−^ *Sema3f*^−/−^ (**E** and **F**) embryos. Similarly, the dorsal longitudinal anastomotical vessel is remodeled in the cephalic perineural vascular plexus in wild type (**A** and **C**) but not in *Sema3a*^−/−^ *Sema3f*^−/−^ (**E** and **G**) embryos. Stereomicroscopic analyses revealed how, when compared with age-matched wild-type embryos (**D**), the development of *Sema3a*^−/−^ *Sema3f*^−/−^ (**H**) E9.5 embryos is severely delayed. Stereomicroscopy analysis (**I** and **J**) of E10.5 wild-type (**I**) and *Sema3a*^−/−^ *Sema3f*^−/−^ (**J**) yolk sacs. *Sema3a*^−/−^ *Sema3f*^−/−^ yolk sacs (**J**) are essentially avascular. **B** and **F**, Magnifications of the top boxed areas in (**A**) and (**E**), respectively. (**C**) and (**G**) are magnifications of bottom boxed areas in (**A**) and (**E**), respectively. Scale bars, 300 μm (**A** and **E**) and 100 μm (**D**, **H**, **I**, and **J**).](atv-37-1710-g010){#F7}

Discussion
==========

The formation of properly patterned intraembryonic and extraembryonic blood vessel networks is crucial to development of vertebrate organisms.^[@R1]^ By counteracting the activity of proangiogenic factors such as VEGFA, antiangiogenic Sema3 proteins, eg, Sema3A and Sema3E, play key roles in shaping blood vascular patterns of developing embryos.^[@R12]^ Here, we unveil how, as a notable exception, Sema3F selectively exerts an effective proangiogenic activity during extraembryonic, but not intraembryonic, vascular development. The defective vascularization of *Sema3f*-null yolk sacs phenocopies the defects of *Nrp1*^−/−^ *Nrp2*^−/−^ embryos that have nearly avascular yolk sacs.^[@R37]^ In addition, we observed that *Sema3f*^−/−^ placentas are also anemic (Results section and Discussion section in the [online-only Data Supplement](http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.117.308226/-/DC1)). Sema3F signaling mainly relies on Nrp2 coreceptor.^[@R6]^ However, in the absence of Nrp2, Sema3F can also signal via Nrp1^[@R38]^ and dissociation constants for Sema3F binding to Nrp1 and Nrp2 are 1.1 and 0.09 nmol/L, respectively.^[@R39]^ Altogether, our and previous data suggests that both Nrp1 and Nrp2 may be required to allow Sema3F-promoting extraembryonic vascular development.

In *Sema3f*^−/−^ yolk sacs, we observed a significant downregulation of Myc, a transcription factor that regulates the expression of several gene sets, such as those promoting developmental^[@R23]^ and tumor^[@R29]^ angiogenesis. Myc protein levels are regulated by GSK3 that, by phosphorylating Myc on Thr58, generates a phosphodegron that enables Fbw7 ubiquitin ligase binding, Myc ubiquitylation, and proteasomal degradation.^[@R25]^ Notably, as previously reported in cultured cells,^[@R25]^ we also found that in *Sema3f*^−/−^ yolk sacs, the drop in Myc protein abundance was combined with an increased Myc Thr58 phosphorylation in Nrp2-expressing VYS EpCs. Fittingly, we also observed that the treatment of in vitro differentiated Nrp2^+^ VYS EpCs with exogenous Sema3F decreases Myc Thr58 phosphorylation, thus promoting Myc accumulation. In EnCs, Sema3F inhibits the phosphatidylinositol 3 kinase-dependent activation of Akt^[@R22]^ that is known to phosphorylate and inactivate GSK3.^[@R40]^ It seems that instead in VYS EpCs autocrine/paracrine Sema3F, by either activating a GSK3 kinase (such as Akt, p90RSK, p70S6K, and PKA) or inhibiting a GSK3-phosphatase (eg, PP2A), impairs the GSK3-dependent phosphorylation of Myc on Thr58 and its ensuing degradation. Further work is needed to establish the diverse molecular mechanisms by which Sema3F may activate or inhibit GSK3 function in different cell types.

MiRNAs are central regulators of cardiovascular development, and Myc promotes the transcription of the miR-17/92 cluster,^[@R26],[@R27]^ whose members miR-18a and miR-19b-1 target the angiogenesis inhibitor Thbs1 hence promoting blood vessel formation.^[@R30],[@R31]^ We revealed how lack of Sema3F results in reduced miR-18a and miR-19b-1 gene transcription, increased Thbs1 protein in VYS EpCs, and dramatically reduced VEGF-R2 tyrosine phosphorylation in vascular EnCs of E9.5 *Sema3f*^−/−^ yolk sacs. Consistently, we also observed that exogenous Sema3F strongly inhibits the expression of Thbs1 protein in in vitro differentiated Nrp2^+^ VYS EpCs.

Our findings unveil a reciprocal cellular cross-talk that supports extraembryonic angiogenesis in the yolk sac (depicted in Figure VI in the [online-only Data Supplement](http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.117.308226/-/DC1)). In VYS EpCs, Sema3F, which is produced by both VYS EpCs and EnCs, signals to counteract the GSK3-driven degradative phosphorylation of Myc on Thr58, thus fostering the Myc-dependent transcription of proangiogenic miR-17/92 cluster members that in turn inhibit the synthesis of the antiangiogenic protein Thbs1 in VYS EpCs themselves, finally allowing EnCs to be elicited by VEGFA, which is also secreted by VYS EpCs and required for yolk sac vascularization.^[@R41]^ In sum, we provide evidence that the extraembryonic proangiogenic activity of Sema3F relies on the Myc-dependent inhibition of the antiangiogenic protein Thbs1, which in turn is an effective inhibitor of VEGF signaling.^[@R33]^ Indeed, the Thbs1 receptor CD36 has been shown to physically interact with VEGF-R2 and hamper its ligand-induced phosphorylation and biological activity on EnCs.^[@R28],[@R33]^ Mechanistically, it was reported that Thbs1 binding to CD36 recruits the SHP-1(Src homology 2 domain--containing protein tyrosine phosphatase-1) to the CD36--VEGF-R2 complex, where SHP-1 dephosphorylates and inactivates VEGF-R2 proangiogenic signaling.^[@R34]^

In light of the fact that another Nrp2-binding semaphorin, that is, SEMA3B, was already suggested to be involved in human preeclampsia,^[@R42]^ our finding that *Sema3f* knockdown severely impairs placentas development and vascularization suggests that an abnormal expression of Sema3F might be implicated in placenta vascular malformations and malignant tumors (Results section, Discussion section, and Figure II in the [online-only Data Supplement](http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.117.308226/-/DC1)).

As previously reported in zebrafish,^[@R9]^ chick,^[@R10]^ and mouse embryos,^[@R8],[@R17]--[@R19]^ here we further substantiate how, differently from Sema3F, Sema3A is a crucial driver of embryonic vascular morphogenesis. Our findings that ≈80% of *Sema3a*-knockout embryos die in utero and display a strong growth retardation compared with wild-type embryos reconcile previous apparently contradicting observations that, based on age and stage matching between wild-type and *Sema3a*-null embryos, concluded that Sema3A does not influence embryonic angiogenesis.^[@R43]^ Furthermore, we establish how Sema3A similarly controls the remodeling of the yolk sac vasculature.

We found that in *Sema3a*-knockout mice, embryonic and extraembryonic blood vessels develop but display severe defects remodeling into an optimized hierarchically branched mature vascular tree. On the contrary, in *Sema3f*-knockout mice, embryonic blood vessels are effectively remodeled into a mature and functional tree, whereas vascularization of extraembryonic tissues is strongly reduced and poorly branched. It seems that, compared with *Sema3f*^−/−^ yolk sacs, the simultaneous knockdown of *Sema3a* and *Sema3f* gene further impairs the vascularization of the yolk sac that, until E12.5, is the primary means of nutrient, gas, and waste exchange for the mouse embryo.^[@R3]^ Therefore, our findings suggest that the further dramatic impairment of embryonic vascular remodeling observed in *Sema3a/Sema3f*-double knockout embryos, compared with *Sema3a*^−/−^ embryos, is conceivably because of the severe disruption of the vasculature of the yolk sac, which constitutes the main nutrient and gas exchange organ between mother and embryo. Our data are in agreement with the fact that the yolk sac constitutes the first main nutrient and gas exchange organ between mother and embryo and with previous observations that mutations causing severe disruption yolk sac blood vessel formation are lethal and result in severe defects in embryo development.^[@R44]--[@R51]^ Finally, the severe disruption of the embryonic vasculature observed in *Sema3a/Sema3f*-double knockout phenocopy the previously described vascular phenotype of double targeted *Nrp1*^−/−^ *Nrp2*^−/−^ embryos.^[@R37]^
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